Optina Diagnostics

About:

Optina Diagnostics develops technology for the early detection of disease through the eye.

Website: http://optinadx.com/

Twitter/X: Optinadx

Top Investors: Creative Destruction Lab (CDL), Innovacorp, Alzheimer's Drug Discovery Foundation, Boehringer Ingelheim Venture Fund, AQC Capital

Description:

Optina Diagnostics is a diagnostics company that uses innovative retinal imaging and artificial intelligence to provide non-invasive diagnostic test results for under-diagnosed diseases. Optina Diagnostics identifies patient retinal features that assist physicians in assessing patients' health status and disease risk in order to provide timely and appropriate care. Optina Diagnostics reimagines brain health assessment and provides critical information early in disease progression.

Total Funding Amount:

$25.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Saint Laurent, Quebec, Canada

Founded Date:

2011-01-01

Contact Email:

info(AT)optinadx.com

Founders:

Chantal Miklosi, David Lapointe

Number of Employees:

11-50

Last Funding Date:

2022-01-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai